Twist Bioscience Corp (0ME.SG)
| Previous close | 19.41 |
| Open | 19.24 |
| Bid | 18.94 x 280000 |
| Ask | 19.19 x 190000 |
| Day's range | 19.24 - 19.24 |
| 52-week range | 10.37 - 39.44 |
| Volume | |
| Avg. volume | 58 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 16 Nov 2023 - 20 Nov 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Business WireTwist Bioscience and IMIDomics Collaborate to Discover Antibodies for Applications in Immune-Mediated Inflammatory Diseases
SOUTH SAN FRANCISCO, Calif. & SAN RAFAEL, Calif. & BARCELONA, September 27, 2023--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and IMIDomics, Inc., a patient-centric drug discovery and development company focused on Immune-Mediated Inflammatory Diseases (IMIDs), today announced a multi-program collaboration whereby Twist will utilize its antigen development capabilities and Libr
Business WireTwist Bioscience to Present at Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif., September 05, 2023--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, will participate in fireside chats at the following upcoming investor conferences:
Business WireTwist Bioscience Enters into Agreement with Ono Pharmaceutical to Discover Novel Antibodies for Autoimmune Diseases
SOUTH SAN FRANCISCO, Calif., August 31, 2023--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a drug discovery agreement with Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President and CEO: Gyo Sagara; "Ono") to discover and develop novel antibodies for the treatment of autoimmune diseases.
